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Objeclives . Evaluation of the mediate nd long-term efficacy
of a novel method of transvenous closure of the patent ductus
arteriosus was the purpose of this study .
Background. In 1981 it the First Moscow hospital, a new
method of transvenous patent ductus arteriosus closure with the
Botallooccluder was developed .
Methods . Transvenous closure of the patent ductus arlerlosus
with the Botallooccluder was carried out in 273 patients . All
patients were r egulariy followed up as oullialients al hitervah. , of3,
6 and 12 mouths after inierventiop , . A total of 171 patients were
examined at a mean of 3 .2 ± 1.1 years (range I to 8) after the
procedure. Late evaluation with cardiac catheterization was per-
formed in 62 patients (36%) ; 50 (29%) of these 62 also underwent
right heart catheterization .
der
Methods of the transcatheter closure of persistently patent
ductus arteriosus have been established as an effective
management modality with no mortality (1-6) . The tech-
nique of Porstmann et al . (2) has proved efficacious in terms
of complete ductus closure and long-term reliability, al-
though a significant rate of arterial entry site complications
and restriction to a mainly adult population have hampered
its popularity . The Rashkind double-disc patent ductus arte-
riosus occluding technique, with no major entry site prob-
lems, is suitable for use in small children and infants (3,4) .
However, up to 11% of patients are left with a persistent
residual left to right shunt, identified by Doppler echocardi-
ography, as late as 40 months after the procedure (7) .
Sii, , ;e 1981 at the First Moscow Hospital, the method of
transvenous patent ductus arteriosus closure with the
"Botallooccluder" has been used in a series of 273 patients
(8,9) . The present study addresses the results of this treat-
ment, with special attention to late follow-up group of 171
patients (63%) .
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Results . Successful implantation was achieved in 266 patients
(97%). The late follow-up findings testify to the favorable clinical
course, with disappearance of the continuous murmur and regres-
sion of the electrocardiographic signs of ventricular overloading in
the vast majority of patients . In 110 case after complete patent
duetus arteriosus closure was a late ductus recanalization ob-
served. No patient had even a minor degree of postprocedural
lower extremity venous damage . In 19 patients (24%), the femoral
artery was imaged by ultrasonography at late follow-up, without
evidence of any vascular abnormality .
Conclusions
. The clinical data suggest high long-term efficacy
and reliability of this technique . Introducer sheaths (12F to 16F
outer diameter) did not cause any long-term entry site sequelae .
(J Am Coil Cardiol 1993,22:1509-14)
Methods
Occlusion technique. Percutaneous patent ductus arterio-
sus closure with the Botalloocciuder has been described in
detail elsewhere (9) . In brief, the Botallooccluder (device for
occlusion of the patent ductus arteriosus, BN-1, NTK
"SovECS") is a conical plug consisting of polyurethane
foam mounted on a stainless steel frame (Fig, 1) . The latter
features a crown of fixing hooks : six in the smaller devices
and eight in the larger ones . The proximal ends of the fixing
hooks are inserted into a metallic holder in the form of a
cartridge provided with an external thread. Therefore, at its
thinner (pulmonary) end, the frame can be affixed to the
thrust catheter of the delivery system by a simple screw-type
attach-release mechanism. The Botallooccluder is currently
available in four sizes : 8, 10, 12 and 14 mm in diameter at its
wider (aortic) end .
The delivery system includes 1) a thin-walled Teflon
introducer sheath (I OF, 12F, 14F and 16F in outer diameter) ;
2) a thrust catheter with a torque clamp for screwing and
unscrewing the connection between it and the occluder ; 3) a
funnel-shaped loader to compress the occluder so that it can
be inserted into the introducer sheath . In patients <5 years
of age, only the IOF and 12F introducer sheaths were used,
whereas the 16F sheath was used only in patients > 10 years
old .
For closure of the patent ductus arteriosus with the
Botallooccluder, the ductus is passed from the pulmonary
0735-1097/93/56-00
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Figure 1 . The Botallooccluder (12 mm) . Note the crown of hooks
for attachment in the ductus (arrows) and the holder (arrowhead),
which is to be attached to the thrust catheter.
artery with the coaxial system under lateral fluoroscopy . The
inner catheter is withdrawn, leaving the introducer sheath
with its distal end in the descending aorta . The occluder is
then screwed onto the stylet of the thrust catheter and
pushed into the loader . Through the loader the occluder is
introduced into the introducer sheath, its larger end first, and
then advanced to the end of the sheath . The sheath is then
pulled back jointly with the occluder, as close as possible to
the aortic origin of the patent ductus arteriosus. The sheath
is carefully withdrawn further while extruding the occluder
into the aortic lumen . The occluder assumes its original
shape, and the entire delivery system (guiding catheter,
thrust catheter and occluder) is slowly withdrawn into the
ductus MAN WAWA is firmly sack, At this moment, the
occluder obturates the lumen, and the fixing hooks penetrate
the walls of the patent ductus arteriosus, preventing dislo-
cation of the device. The thrust catheter is unscrewed from
the occluder, leaving the latter in the ductus (Fig . 2) .
Study pa tits. Between December 1981 and November
1991, transcatheter patent ductus arteriosus closure with the
Botallooccluder was attempted in a total of 273 patients,
including 202 female patients (74%), with a mean age of
9.2 ± 3.5 years (range 2 to 43) . All patients had an isolated
patent ductus aAeriosus, including 13 patients with recanal-
ization of the ductus after surgical closure . Informed consent
was obtained from all adult patients and the parents of
children who underwent percutaneous patent ductus arteri-
osus closure as well as late invasive follow-up examination .
The patent ductus arteriosus closure was preceded by
cardiac catheterization and ductus angiography in all pa-
tients. Pulmonary pressures were normal in 181 patients (up
to 30 mm Hg) and elevated in 92 (up to 80 mm Hg) . A
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Figure 2. A, lortogram in the lateral projection, demonstrating a
patent ductus arteriosus (arrows) that is approximately 4 mm in
diameter in a 6-year old boy . B, Aortogram 15 min after the
occlusion procedure, demonstrating complete closure of the ductus .
Arrow points to the occluder within the patent ductus arteriosus .
pulmonary/systemic blood flow ratio (Qp/Qs) <13 was
recorded in 73 patients (27%), between 1 .3 and 1 .5 in 121
patients (44%) and >1 .5 in 79 patients (29%) .
All patients were regularly followed up (or continue to be
followed up) on an outpatient basis at intervals of 3, 6 and 12
months after intervention . From 1987 to 1991, the results in
patients who had successful patent ductus arteriosuss closure
> I year earlier were studied . The late follow-up information
was obtained in a total of 171 patients (131 female, 40 male)
at a mean of 3 .2 ± 2.1 years (range I to 8) after the
procedure . Mean age at the time of the last follow-up visit
was 13 .5 ± 2.2 years (range 4 to 48) . The clinical evaluation
of 120 patients (70%) was performed in our hospital .
Follow-up information about the remaining 51 patients (30%)
was received from the treating physicians .
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Follow-up exanainiflons. Other than auscultation, the
only noninvasive diagnostic techniques used until 1986 were
phonocardiography, electrocardiography and thoracic radi-
ography in two planes . In 1986, two-dimensional echocaidi-
ography with pulsed Doppler study became available and
was used ;, ; ;" : (54 -1
Z)
before and from I to 7 days
after the procedure . This technique was also applied in all
120 patients who came for late follow-up at our institution .
Studies were first performed on an Aloka 280 LS and later
(since 1989) on an ATL Ultramark 8 . The latter was also
used for long-term femoroiliac venous segment examination
in 29 patients (24% of the late follow-up group) .
Thoracic aortography was performed for short-term
follow-up (2 weeks to 3 months after the procedure) in 12
patients and for long-term follow-up (I to 7 years after the
procedure) in 62 patients (36%) who gave consent for repeat
aortography . Fifty (29%) of these 62 patients also ui"~rwent
right heart catheterization .
Statistical analysis . Data were expressed as mean value
SD. Continuous data were compared using the uvipaired t
test and event rates using the chi-square test . A p value <
0.05 was considered sufficient to reject the null hypothesis of
equality of the two samples . The prevalence of residual
ductal shunting was evaluated using a Kaplan-Meier prod-
uct-limit analysis te, hnique .
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Figure 3. A, Aortogram in the lateral projection 3 years after
insertion of the occluder in a 21-year old woman, demonstrating a
complete patent ductus arteriosus closure . B, Repeat aortogram 2 .5
years after insertion of the occluder in a 17-year old woman,
demonstrating complete closure of the patent ductus arteriosus with
the large residual dimple (arrows) .
Results
here were no deaths in this series . In no patient with
initially successful transcatheter patent ductus arteriosus
closure was late ductus recanalization seen, either during the
1st year after intervention or during long-term follow-up
(Fig . 3) . In all, a favorable clinical course with disappearance
of the continuous murmur and the electrocardiographic signs
of ventricular overloading was observed . The hemodynamic
findings showed normalization of the pulmonary artery pres-
sure/aortic pressure ratio (39 .6 t 1 .1% before vs . 24 .3 ±
1 .1% after patent ductus arteriosus closure, p < 0 .01) and no
residual shunting in the late catheterization group.
Immediate embolization of the Botallooccluder to the
systemic circulation occurred in seven patients (3%) (Table
1) . In four patients, failure to correctly position the occluder
in the patent ductus arteriosus caused the occluder to
embolize into the bifurcation of the abdominal aorta . All four
patients underwent urgent surgical retrieval of the device,
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TAk 1 . Results of Patent Ductus Arteriosus Closure in
273 Patients
DL - ductus libation ; DR - device removal ; ES - elective surgery
;
PDA ei patent ductus arteriosus ; SD - second device placement ; US
urgent surgery,
with simultaneous patent ductus arteriosus ligation . In three
patients, after underestimation of the ductus size and inabil-
ity to fix the device in the ductus, the occluder migrated into
the pulmonary artery . In all, the patent ductus arteriosus
was successfully closed with a second, larger device, and the
device that migrated was left in the pulmonary artery bed (it
is not usually feasible to retrieve the embolized occluder
from the pulmonary artery branch because it easily becomes
stuck there) . Two of these patients developed clinical find-
ings of localized pneumonia that resolved within 6 days,
whereas the third patient had no sequelae. All four patients
were followed up for 2,5 years, and one underwent calhe-
terization 5 months after the procedure . In no patients were
signs of long-term pulmonary compromise observed . In the
patient who underwent catheterization, pulmonary arteriog-
raphy showed complete occlusion of one of the left inferior
segmental pulmonary artery branches . However, no hemo-
dynamic or gas saturation abnormalities were seen .
In three patients (M), after failure to determine the
precise location of the patent ductus arteriosus, the Botal-
looiccluder was prematurely released after it became at-
tached to the ostium of the left subelavian artery in two
patients and to the wall of the descending aorta in one
patient . These three patients required surgical intervention
for removal of the misplaced occluder, which was followed
by patent ductus arteriosus ligation .
Before occlusion, all patients presented with a continuous
patent ductus arteriosus murmur. Just after the occlusion
procedure, in 103 patients (38%) a mild systolic murmur
persisted in the pulmonary area . In six patients (10 days to
3 months after the procedure), angiography or two-
dimensional echocardiography with Doppler study showed
no evidence of residual shunting
. Among the patients who
were followed up at our institution > 1 year after occlusion,
19 (16%) had a residual low amplitude systolic murmur. Ten
of them consented to undergo catheterization . In all, com-
plete Occlusion of the ductus was confirmed . Nevertheless,
in six patients in the late follow-up group and in two patients
examined shortly after the procedure, the presence of a large
residual dimple (6 to 13 mm in depth) at the location of the
Figure 4. Two-dimensional echocardiograph from a patient with a
residual low amplitude systolic murmur 1 .5 years after patent ductus
arteriosus closure, Arrows indicate the thinner end of the Botallooc-
cluder bulging into the pulmonary artery lumen .
former origin of the
patent
ductus arteriosus (Fig . 38) was
evident on angiography . Furthermore, in 60% of patients
with a residual systolic murmur at echocardiography, either
a marked propagation of the occluder into the pulmonary
artery lumen (Fig . 4) or an enlarged residual patent ductus
arteriosus dimple, or both, was visualized .
Eight of the 266 patients had incomplete ductus closure
with the Botallooccluder (Fig . 5). Failure to occlude the
ductus completely was suspected by a continuous flow
murmur at routine auscultation and phonocardiography in all
cases during the first few days after the procedure and was
confirmed first by echocardiographic and Doppler studies
and later (after 2 weeks to 6 months) by catheterization . Five
patients with a residual shunt varying from 25% to 40% of
Figure 5. Graphic presentation of results of Kaplan-Meier product-
limit analysis of ductal occlusion from day I to 8 years in 266
patients (97%) with successful placement of the device in the patent
ductus arteriosus, The reduction of residual shunting at 6 months as
a result of subsequent ductus surgery is noted . Error bars indicate 2
SEM .
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Result
No . % Additional Therapy
Permanent successful occlusion 258 95
Incomplete PDA closure 8 3
ES: DL (5 patients)
Complications 10 4
Embolization of occluder 7 3
into aortic bifurcation 4 US: DR + DL
Into pulmonary artery 3 SD
Misplacement of occluder 3 I
In the left subelavian ostium
In the aortic wall
US: DR + DL
US: DR + DL
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pulmonary circulation had elective surgery in the period
between 2 weeks and 6 months after the procedure . In all, at
operation the partially patent ductus was ligated and the
device left in place . The remaining three patients with a
residual shunt :520% are currently being followed up . All
eight patients with and without operation are doing well and
are asymptomatic .
Thoracic radiographs showed in all patients correct posi-
tioning of the occluder (Fig . 6) in the ductus, which did not
change over time in the majority of cases . In five patients
(4%), later radiographs revealed an insignificant shift of the
occluder (from 3 to 5 mm) in one or both views, without any
evidence of ductus recanalization .
There were no immediate entry site complications in this
patient series . Special attention was paid to the patients
returning to the hospital to determine any minor sign of low
extremity venous insufficiency on the side of the procedure .
In 29 patients (24%) the femoral venous system was studied
with the duplex echocardiographic scan . In no patient who
came to the hospital was even a minor degree of postproce-
dural lower extremity venous damage found, and in no case
was it noted on the questionnaire completed by the patients'
treating physicians .
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Figure 6 . Thoracic radiographs in the frontal (A) and lateral (B)
projections, demonstrating the correct position of the occluder .
Discussion
The Porstmann plug for patent ductus arteriosus closure,
made of the polyvinyl alcohol foam (Ivalon), has been used
for >25 years in the clinical setting . Long-term reliability of
patent ductus arteriosus closure has been observed in a large
series of patients treated with this device (2,10) . Good tissue
tolerance and morphologic consequences of its implantation
into the vessels have been shown in animal and autopsy
studies (2,11) . However, the late results of patent ductus
arteriosus treatment with the Rashkind polyurethane foam
occluder, used since 1979, are now being studied and have
not yet been fully described in published reports . The device
used here (Botallooccluder) showed an immediate success
rate of 95% (6,9) . Despite the significant differences in
construction, it is also made of polyurethane foam and is
inserted by the transvenous approach . Therefore, certain
clinical observations from our study can also be useful with
regard to the Rashkind device .
In all patent ductus arteriosus closure techniques, the rate
of embolic complications is <5% and diminishes with the
operator's experience (2,5,12)
. In our experience the major-
ity of the complications occurred during the early learning
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curve and when new operators became involved in the
program .
Residual transductal shunting occurs in 15% to 20% of
patients treated with the Rashkind technique (12,13), and in
11% of patients it persists up to 40 months of follow-up (7) .
We observed incomplete closure in eight patients (3%) . In all
eight it was caused by underestimation of the patent ductus
arteriosus diameter, mostly at the beginning of our experi-
ence. We avoided this problem by careful patient selection
and use of occluders of sufficient size . Unlike the Rashkind
technique, we did not observe further closure of an incom-
pletely closed ductus during follow-up (Fig . 5) . This differ-
ence in clinical outcome of partially occluded ductus prob-
ably depends on the differences in construction of each
device. Obviously, after being placed, the Rashkind device
remains permeable to blood, which passes through the small
spaces between the disc and ductus walls and probably
through the pores in the polyurethane mesh . With time, the
small leaks become occluded by the thrombi or by ingrowing
endothelium and connective tissue, or both . However, large
leaks, if any, can remain for years (7). In the case of the
Botallooccluder, the plastic plug itself is rather thick and
impermeable to blood . The leaks at the side of the plug, due
to a relatively insufficient amount of foam, are always too
large to close spontaneously .
Limits of the study. The ahsenc" of color flow Dopp-
ler, in our opinion, does not influence the accuracy of this
analysis . In all patients who underwent control angiography,
the results confirmed the information obtained by the non-
invasive diagnostic techniques without a single case of
divergence, Actually, we consider the combination of these
diagnostic modalities, including pulsed Doppler echocardi-
ography, to be sufficient for transcatheter patent ductus
arteriosus closure control and residual shunting determina-
tion.
Cll This study showed that residual
systolic murmur after t"e occluder placement is not associ-
ated with Partial ductus occlusion, In our opinion, the
marked pro tion of the occluder into the pulmonary
artery lumen or an enlarged residual patent ductus arteriosus
dimple, or both, may have caused the insignificant systolic
murmur in the pulmonary artery . Thus, in the majority of
patients it was possible to find the underlying anatomic
substrate of the murmur. When it was not possible to find the
apparent cause of this sound phenomenon, it was considered
to be probably due to the remaining pulmonary artery
enlargement after patent ductus arteriosus closure and the
relatively narrow pulmonary annulus . Further reduction in
the percent of patients with residual postprocedure systolic
murmur (38 immediately after the procedure vs . 16%
during late follow-up) supports this speculation. The de-
crease in the patent ductus arteriosus residual dimple vol-
ume and endothelialization of the oca
°r's surfaces, prop-
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agated into the great vessels, in response to connective
tissue reaction, could also contribute to this phenomenon .
Apparently, an insignificant shift in occluder position found
on the late thoracic radiographs could be caused by the
patient's growth or by scar formation, or both, both poten-
tially leading to positional changes inside the chest .
Conclusions . Our data suggest that transcatheter closure
of the patent ductus arteriosus with the Rotallooccluder is an
efficacious procedure in providing complete permanent duc-
tus closure . The residual low ~-tmplitude systolic murmur in
the pulmonary artery does not indicate incomplete patent
ductus arteriosus closure . The utilization of the relatively
large (12F to 16F outer diameter) transvenous introducer
sheaths did not cause any entry site sequelae, and the
application of much larger cannulas may be justified in the
adult patient with an oversized ductus . The clinical course
suggests that patent ductus art: riosu closure is complete
immediately after the procedure, there is no need to follow
up the patient who can be fully rehabilitated within I month
of the closure .
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